优化Chlorella vulgaris的种植,以提高生物质和氨酸生产
Kangping Wu1,2, Jiangling Lai1, Qi Zhang1
1State Key Laboratory of Food Science and Resources, Engineering Research Center for Biomass Conversion, Ministry of Education, Nanchang University, Nanchang 330047, China.
Foods (Basel, Switzerland)
|August 29, 2024
概括
通过优化Chlorella vulgaris的混合营养培养,可以实现高效的黄蛋白生产. 这种微藻提供了一种可持续的替代方案,以满足日益增长的对价值抗氧化剂黄蛋白的需求.
科学领域:
- 生物技术是生物技术.
- 微藻养殖 微藻养殖
- 自然产品提取 提取自然产品
背景情况:
- 氨酸是一种抗氧化剂,在医学,医疗保健和食品中至关重要.
- 传统的黄提取难以满足不断增长的黄蛋白需求.
- 像Chlorella vulgaris这样的微藻类是潜在的替代来源.
研究的目的:
- 优化Chlorella vulgaris的种植,以实现高效的黄蛋白生产.
- 调查各种条件对生物质和黄蛋白产量的影响.
- 为了建立一个工业规模的蛋白生产的基础,使用微藻.
主要方法:
- 菌的混合培养.
- 优化源 (酸),C:N比率 (12:1),N:P比率 (10:1) 和光持续时间 (24小时).
- 对生物质度,生产率,生长产量,叶绿素,胡卜素,黄蛋白和蛋白质含量的分析.
主要成果:
- 在优化条件下,生物质度为6.08g·L-1和生产率为1.00g·L-1 .
- 氨酸度达到15.02毫克·L-1的含量为2.47毫克·g-1.
- 还观察到高度的叶绿素,胡卜素和蛋白质.
结论:
- 优化的混合营养培养显著提高了Chlorella vulgaris生物质和黄蛋白生产.
- 菌是工业化蛋白提取的可行和高效来源.
- 这项研究为扩大微藻类蛋白生产提供了基础.
相关概念视频
Bioreactor Controls-III
55
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
55
Designing Growth Media for Bioreactors
67
Growth media provide essential nutrients that support cell growth and metabolism, thereby enhancing the yield of valuable products such as enzymes, antibiotics, and biomass. Designing an effective growth medium involves balancing all components to prevent nutrient limitations or toxic excesses, both of which can impair growth and reduce product yields.Composition of a Typical Growth MediumA typical growth medium contains carbon and nitrogen sources, salts, vitamins, trace elements, and...
67
Upstream Processing
87
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
87


